| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Guizhou Xinbang Pharmaceutical Co. Ltd (SHE: 002390)
002390 Technical Analysis
1.5
| As on 10th Dec 2025 002390 STOCK Price closed @ 4.15 and we RECOMMEND Buy for LONG-TERM with Stoploss of 3.79 & Sell for SHORT-TERM with Stoploss of 4.15 we also expect STOCK to react on Following IMPORTANT LEVELS. |
002390STOCK Price
| Open | 3.78 | Change | Price | % |
| High | 4.15 | 1 Day | 0.38 | 10.08 |
| Low | 3.76 | 1 Week | 0.32 | 8.36 |
| Close | 4.15 | 1 Month | 0.31 | 8.07 |
| Volume | 147345097 | 1 Year | 0.27 | 6.96 |
| 52 Week High 4.85 | 52 Week Low 3.37 | ||||
SHE China Most Active Stocks
| 002217 | 3.71 | -1.85% |
| 000564 | 2.66 | 3.50% |
| 000725 | 4.18 | 0.24% |
| 000002 | 5.25 | 10.06% |
| 000078 | 4.83 | 4.32% |
| 000547 | 20.74 | -6.28% |
| 002512 | 8.04 | 2.55% |
| 300189 | 6.88 | 20.07% |
| 002413 | 9.08 | -7.16% |
| 000592 | 12.49 | 3.91% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
| 002390 Daily Charts |
002390 Intraday Charts |
Whats New @ Bazaartrend |
002390 Free Analysis |
|
|
002390 Important Levels Intraday
| RESISTANCE | 4.90 |
| RESISTANCE | 4.66 |
| RESISTANCE | 4.51 |
| RESISTANCE | 4.36 |
| SUPPORT | 3.94 |
| SUPPORT | 3.79 |
| SUPPORT | 3.64 |
| SUPPORT | 3.40 |
002390 Forecast December 2025
| 4th UP Forecast | 6.66 |
| 3rd UP Forecast | 5.85 |
| 2nd UP Forecast | 5.36 |
| 1st UP Forecast | 4.86 |
| 1st DOWN Forecast | 3.44 |
| 2nd DOWN Forecast | 2.94 |
| 3rd DOWN Forecast | 2.45 |
| 4th DOWN Forecast | 1.64 |
002390 Weekly Forecast
| 4th UP Forecast | 5.71 |
| 3rd UP Forecast | 5.21 |
| 2nd UP Forecast | 4.90 |
| 1st UP Forecast | 4.59 |
| 1st DOWN Forecast | 3.71 |
| 2nd DOWN Forecast | 3.40 |
| 3rd DOWN Forecast | 3.09 |
| 4th DOWN Forecast | 2.59 |
002390 Forecast2025
| 4th UP Forecast | 7.45 |
| 3rd UP Forecast | 6.39 |
| 2nd UP Forecast | 5.74 |
| 1st UP Forecast | 5.08 |
| 1st DOWN Forecast | 3.22 |
| 2nd DOWN Forecast | 2.56 |
| 3rd DOWN Forecast | 1.91 |
| 4th DOWN Forecast | 0.85 |
Guizhou Xinbang Pharmaceutical Co. Ltd ( SHE China Symbol : 002390 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
002390 Other Details
| Segment | EQ | |
| Market Capital | 13035087872.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > echo $website ; ?> | |
002390 Address
![]() |
||
002390 Latest News
002390 Business Profile
Guizhou Xinbang Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of Chinese herbal medicines and biological drugs in China and internationally. It offers cardiovascular and cerebrovascular, digestive system, endocrine, tumor and immune regulation, blood system, rheumatism and rheumatoid, urinary system, antipyretic analgesic, cold medication, gynecological treatment, and anti-infective drugs. The company was founded in 1995 and is headquartered in Guiyang, China. Address: Intersection of Hangtian Avenue and Xint, Guiyang, China, 550018
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

